News & Updates

Swarming microrobotic platform enables aneurysm embolization with high fifilling ratio

Dapagliflozin helps prevent heart failure events, cardiovascular death

Treatment with dapagliflozin leads to a reduction in the rate of total heart failure (HF) events and cardiovascular death, irrespective of patient characteristics such as ejection fraction (EF), according to data from the DELIVER* trial.

Early hysterectomy poses increased CVD risk

Undergoing early hysterectomy appears to put women at heightened risk of a composite of cardiovascular disease (CVD), especially stroke, as reported in a study.

Atrial fibrillation patients use same anticoagulant after bleeding event

A recent study has shown that the majority of patients with nonvalvular atrial fibrillation who have had a bleeding event resume anticoagulation therapy usually with the same drug class that they have been using.

Thiazide plus potassium-sparing diuretics outdoes monotherapy in hypertension

Use of thiazides with potassium-sparing (PS) diuretics results in greater blood pressure (BP)-lowering efficacy, as well as reduces hypokalaemia and hyperglycaemia, compared with thiazides alone, reports a recent study.

Sacubitril/valsartan outdoes valsartan on ventricular remodeling in perimenopausal hypertension

Treatment with sacubitril/valsartan appears to be better than valsartan alone in reversing ventricular remodeling in perimenopausal hypertensive women, suggests a study.

Loperamide, mitragynine linked to ventricular arrhythmias

Use of nonprescription drugs loperamide and mitragynine appears to contribute to the risk of life-threatening ventricular arrhythmia, reports a study in North America.